WGS and WTS in leukaemia: A tool for diagnostics?

4Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The diagnosis of haematological malignancies requires a plethora of methods to evaluate primarily the morphology, but also immunophenotypic and genetic markers. However, intratumoural and interpatient tumour heterogeneity present a challenge when it comes to achieve early diagnosis and informed treatment decisions. Here, the clinical potential of personalized genome and transcriptome sequencing as a comprehensive diagnostic approach is just beginning to be realized, whereas the analysis and clinical interpretation of the acquired data requires a solid knowledge base and sophisticated bioinformatics workflows. Personalized sequencing is already clinically applied and offers the possibility to refine molecular diagnostics, to more accurately assess disease risk and to optimize and personalize treatment decisions. This article reflects the current status of whole genome and transcriptome sequencing as a diagnostic tool for haematological neoplasms, describes pre-analytical and analytical considerations and discusses the current challenges and limitations of the approach.

Cite

CITATION STYLE

APA

Meggendorfer, M., Walter, W., & Haferlach, T. (2020, September 1). WGS and WTS in leukaemia: A tool for diagnostics? Best Practice and Research: Clinical Haematology. Bailliere Tindall Ltd. https://doi.org/10.1016/j.beha.2020.101190

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free